Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: Construction of a new generation of spleen necrosis virus-derived retroviral vectors

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6480-6488

  Parveen, Zahida ^a,b   Mukhtar, Muhammad ^a,b   Goodrich, Adrienne ^a,b   Acheampong, Edward ^a,b   Dornburg, Ralph ^a,b   Pomerantz, Roger J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTEGRASE; POL PROTEIN; RETROVIRUS VECTOR; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; SPLEEN NECROSIS VIRUS PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NONLENTIVIRAL RETROVIRUS; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; RETROVIRUS; SPLEEN NECROSIS ONCOVIRUS; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; GENE PRODUCTS, POL; GENETIC VECTORS; HIV INTEGRASE; HIV-1; HUMANS; INTEGRASES; MOLECULAR SEQUENCE DATA; RETICULOENDOTHELIOSIS VIRUSES, AVIAN; RETROVIRIDAE PROTEINS; RNA, VIRAL; TRANSDUCTION, GENETIC; TRANSFECTION; VIRUS ASSEMBLY;

EID: 2642534287     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6480-6488.2004     Document Type: Article

References (51)

1. Asante-Appiah, E., and A. M. Skalka. 1999. HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv. Virus Res. 52:351-369.
2. Bacharach, E., J. Gonsky, D. Lim, and S. P. Goff. 2000. Deletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5′ plus-strand DNA ends in vivo. J. Virol. 74:4755-4764.
3. Beale, K. K., and W. E. Robinson, Jr. 2000. Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1. Antivir. Res. 46:223-232.
4. Beasley, B. E., and W. S. Hu. 2002. cis-Acting elements important for retroviral RNA packaging specificity. J. Virol. 76:4950-4960.
5. Brincat, J. L., J. K. Pfeiffer, and A. Telesnitsky. 2002. RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J. Virol. 76:88-95.
6. Browning, M. T., R. D. Schmidt, K. A. Lew, and T. A. Rizvi. 2001. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75:5129-5140.
7. Butsch, M., S. Hull, Y. Wang, T. M. Roberts, and K. Boris-Lawrie. 1999. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73:4847-4855.
8. Certo, J. L., T. O. Kabdulov, M. L. Paulson, J. A. Anderson, and W. S. Hu. 1999. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA. J. Virol. 73:9170-9177.
9. Certo, J. L., B. F. Shook, P. D. Yin, J. T. Snider, and W. S. Hu. 1998. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J. Virol. 72:5408-5413.
10. Chen, Y., and P. L. Marion. 1996. Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA. J. Virol. 70:6151-6156.
11. Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins, and J. D. Thompson. 2003. Multiple sequence alignment with the CLUSTAL series of programs. Nucleic Acids Res. 31:3497-3500.
12. d'Angelo, J., J. F. Mouscadet, D. Desmaele, F. Zouhiri, and H. Leh. 2001. HIV-1 integrase: the next target for AIDS therapy? Pathol. Biol. 49:237-246.
13. Dougherty, J. P., and H. M. Temin. 1986. High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol. Cell. Biol. 6:4387-4395.
14. Dougherty, J. P., and H. M. Temin. 1987. A promoterless retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc. Natl. Acad. Sci. USA 84:1197-1201.
15. Drelich, M., R. Wilhelm, and J. Mous. 1992. Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology 188:459-468.
16. Engelman, A., and R. Craigie. 1992. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:6361-6369.
17. Esposito, D., and R. Craigie. 1999. HIV integrase structure and function. Adv. Virus Res. 52:319-333.
18. Fu, W., and W. S. Hu. 2003. Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle. J. Virol. 77:754-761.
19. Garces, J., and R. Wittek. 1991. Reverse-transcriptase-associated RNase H activity mediates template switching during reverse transcription in vitro. Proc. R. Soc. Lond. B Biol. Sci. 243:235-239.
20. Gautier, R., A. Jiang, V. Rousseau, R. Dornburg, and T. Jaffredo. 2000. Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells. J. Virol. 74:518-522.
21. Goldgur, Y., R. Craigie, G. H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D. R. Davies. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA 96:13040-13043.
22. Goldgur, Y., F. Dyda, A. B. Hickman, T. M. Jenkins, R. Craigie, and D. R. Davies. 1998. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA 95:9150-9154.
23. Harper, A. L., M. Sudol, and M. Katzman. 2003. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J. Virol. 77:3838-3845.
24. Ilyinskii, P. O., and R. C. Desrosiers. 1998. Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus. EMBO J. 17:3766-3774.
25. Jayaram, M. 1997. The cis-trans paradox of integrase. Science 276:49-51.
26. Katzman, M., R. A. Katz, A. M. Skalka, and J. Leis. 1989. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63:5319-5327.
27. Katzman, M., and M. Sudol. 1995. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases, J. Virol. 69:5687-5696.
28. Katzman, M., and M. Sudol. 1998. Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins. J. Virol. 72:1744-1753.
29. Katzman, M., M. Sudol, J. S. Pufnock, S. Zeto, and L. M. Skinner. 2000. Mapping target site selection for the nonspecific nuclease activities of retroviral integrase. Virus Res. 66:87-100.
30. Kaye, J. F., and A. M. Lever. 1998. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72:5877-5885.
31. Liu, H., X. Wu, H. Xiao, and J. C. Kappes. 1999. Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1. J. Virol. 73:8831-8836.
32. Moreau, K., C. Faure, G. Verdier, and C. Ronfort. 2002. Analysis of conserved and non-conserved amino acids critical for ALSV (avian leukemia and sarcoma viruses) integrase functions in vitro. Arch. Virol. 147:1761-1778.
33. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
34. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
35. Neamati, N., C. Marchand, and Y. Pommier. 2000. HIV-1 integrase inhibitors: past, present, and future. Adv. Pharmacol. 49:147-165.
36. O'Brien, C. 1994. HIV integrase structure catalyzes drug search. Science 266:1946.
37. Panganiban, A. T., and H. M. Temin. 1984. The retrovirus pol, gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc. Natl. Acad. Sci. USA 81:7885-7889.
38. Parveen, Z., A. Krupetsky, M. Engelstadter, K. Cichutek, R. J. Pomerantz, and R. Dornburg. 2000. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat. Biotechnol. 18:623-629.
39. Parveen, Z., M. Mukhtar, M. Rafi, D. A. Wenger, K. M. Siddiqui, C. A. Siler, B. Dietzschold, R. J. Pomerantz, M. J. Schnell, and R. Dornburg. 2003. Cell-type-specific gene detivery into neuronal cells in vitro and in vivo. Virology 314:74-83.
40. Pommier, Y., C. Marchand, and N. Neamati. 2000. Retroviral integrase inhibitors year 2000: update and perspectives. Antivir. Res. 47:139-148.
41. Restle, T., B. Muller, and R. S. Goody. 1992. RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms. FEBS Lett. 300:97-100.
42. Roberts, T. M., and K. Boris-Lawrie. 2003. Primary sequence and secondary structure motifs in spleen necrosis virus RU5 confer translational utilization of unspliced human immunodeficiency virus type 1 reporter RNA. J. Virol. 77:11973-11984.
43. Russell, R. A., R. Critchley, G. Vassaux, and M. O. McClure. 2002. Human foamy virus integrase fails to catalyze the integration of a circular DNA molecule containing an LTR junction sequence. Gene Ther. 9:1326-1332.
44. Schatz, O., J. Mous, and S. F. Le Grice. 1990. HIV-1 RT-associated ribonuclease H displays both endonuclease and 3′-5′ exonuclease activity. EMBO J. 9:1171-1176.
45. Sevilya, Z., S. Loya, N. Adir, and A. Hizi. 2003. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit. Nucleic Acids Res. 31:1481-1487.
46. Skinner, L. M., S. L. Lamers, J. C. Sanders, M. E. Eyster, M. M. Goodenow, and M. Katzman. 1998. Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:99-110.
47. Trentin, B., N. Rebeyrotte, and R. Z. Mamoun. 1998. Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity. J. Virol. 72:6504-6510.
48. Tsai, W. P., T. D. Copeland, and S. Oroszlan. 1985. Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag gene-encoded structural proteins. Virology 140:289-312.
49. Tsurutani, N., M. Kubo, Y. Maeda, T. Ohashi, N. Yamamoto, M. Kannagi, and T. Masuda. 2000. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74:4795-4806.
50. Wu, X., H. Liu, H. Xiao, J. A. Conway, E. Hehl, G. V. Kalpana, V. Prasad, and J. C. Kappes. 1999. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73:2126-2135.
51. Zhao, J., G. J. Pettigrew, J. Thomas, J. I. Vandenberg, L. Delriviere, E. M. Bolton, A. Carmichael, J. L. Martin, M. S. Marber, and A. M. Lever. 2002. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res. Cardiol. 97:348-358.